---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-052149"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2026-08-04T11:09:38+00:00"
generated_at: "2026-08-04T11:15:28.842999+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q2 net loss $145.3M; revises FY2026 guidance down; divests Diabetes Health for $235M

## Summary
- Net revenue $740.3M (+12.7% YoY); organic growth 15.9%; net loss $145.3M vs net income $4.2M in prior year.
- Adjusted EBITDA $132.0M, down 3.2% YoY; includes $144.2M pre-tax goodwill impairment.
- FY2026 guidance revised: revenue $2.85-2.89B, Adj. EBITDA $490-520M, free cash flow $80-120M (from prior $680-730M Adj. EBITDA).
- Definitive agreement to sell Diabetes Health business for $235M cash; presented as discontinued operations.
- New capitated agreements: West Coast IDN at run-rate; Humana OneHome in FL/TX for ~478K members.

## SEC filing metadata
- accession: 0001628280-26-052149
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2026-08-04T11:09:38+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828026052149/0001628280-26-052149-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828026052149/ahco-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-052149
- JSON: https://secwatch.observer/filing/0001628280-26-052149.json
- Plain text: https://secwatch.observer/filing/0001628280-26-052149.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.